A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Систематический обзор антительного иммунитета к коронавирусам: кинетика, корреляты защиты и связь с тяжестью заболевания
2020-09-17
SCID: 54.1/qy5bgexm
Discuss with AI
antibody kineticsantibody-mediated immunitycoronavirusescorrelates of protectionpopulation seroprevalence
Figures from the paper
Abstract (AI)
Abstract Many public health responses and modeled scenarios for COVID-19 outbreaks caused by SARS-CoV-2 assume that infection results in an immune response that protects individuals from future infections or illness for some amount of time. The presence or absence of protective immunity due to infection or vaccination (when available) will affect future transmission and illness severity. Here, we review the scientific literature on antibody immunity to coronaviruses, including SARS-CoV-2 as well as the related SARS-CoV, MERS-CoV and endemic human coronaviruses (HCoVs). We reviewed 2,452 abstracts and identified 491 manuscripts relevant to 5 areas of focus: 1) antibody kinetics, 2) correlates of protection, 3) immunopathogenesis, 4) antigenic diversity and cross-reactivity, and 5) population seroprevalence. While further studies of SARS-CoV-2 are necessary to determine immune responses, evidence from other coronaviruses can provide clues and guide future research.
Key Findings
1
A systematic search screened 2,452 abstracts and identified 491 relevant manuscripts across five predefined research areas.
2
Evidence from previously studied coronaviruses can inform SARS-CoV-2 immune-response research, although additional SARS-CoV-2 studies remain necessary.
3
The review evaluates antibody-mediated immunity across SARS-CoV-2, SARS-CoV, MERS-CoV, and endemic human coronaviruses.
4
The review focuses on antibody kinetics, correlates of protection, immunopathogenesis, antigenic diversity and cross-reactivity, and population seroprevalence.
5
Understanding infection- or vaccine-induced protective immunity is essential for predicting future coronavirus transmission and disease severity.
Research Object
antibody-mediated immunity to human coronaviruses, including SARS-CoV-2, SARS-CoV, MERS-CoV, and endemic HCoVs
Research Subject
the kinetics, correlates of protection, immunopathogenesis, antigenic diversity and cross-reactivity, and population seroprevalence of coronavirus antibody immunity, including its association with disease severity
Publication Details
Publication Date
2020-09-17
Journal
Nature Communications
Publisher
Nature Portfolio
ISSN
2041-1723
Cited by
1057
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Origin and evolution of pathogenic coronaviruses2018
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice2004
Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nucleoprotein2007